SEC Form 4 · accession 0001179110-15-007643
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael R Minogue
Officer — President, CEO, Chairman · Director
Period of report
May 8, 2015
Accepted (ET)
May 12, 2015 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 par value | May 8, 2015 | M | 42,202 | $11.27 | A | 374,674 | D | |
| Common Stock $.01 par value | May 8, 2015 | M | 15,000 | $13.80 | A | 389,674 | D | |
| Common Stock $.01 par valueF5,F6 | May 8, 2015 | S | 10,805 | $64.1598 | D | 378,869 | D | |
| Common Stock $.01 par valueF5,F7 | May 8, 2015 | S | 12,129 | $65.1294 | D | 366,740 | D | |
| Common Stock $.01 par valueF5,F8 | May 8, 2015 | S | 6,372 | $66.3304 | D | 360,368 | D | |
| Common Stock $.01 par valueF5,F9 | May 8, 2015 | S | 16,266 | $67.3336 | D | 344,102 | D | |
| Common Stock $.01 par valueF5,F10 | May 8, 2015 | S | 9,213 | $67.8776 | D | 334,889 | D | |
| Common Stock $.01 par valueF5,F11 | May 8, 2015 | S | 2,175 | $69.0306 | D | 332,714 | D | |
| Common Stock $.01 par valueF5,F12 | May 8, 2015 | S | 242 | $69.81 | D | 332,472 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.27 | May 8, 2015 | M | 42,202 | D | May 30, 2008 | May 30, 2017 | Common Stock | 42,202 | 0 | D |
| Stock Option (right to buy)F1,F2 | $13.80 | May 8, 2015 | M | 15,000 | D | May 23, 2009 | May 23, 2018 | Common Stock | 15,000 | 28,333 | D |
| Stock Option (right to buy)F1 | $13.57 | holding | — | — | — | Jun 1, 2007 | Jun 1, 2016 | Common Stock | 0 | 82,000 | D |
| Stock Option (right to buy)F3,F4 | $18.63 | holding | — | — | — | Jun 15, 2009 | Aug 13, 2018 | Common Stock | 0 | 76,875 | D |
| Stock Option (right to buy)F3,F2 | $5.86 | holding | — | — | — | May 28, 2010 | May 28, 2019 | Common Stock | 0 | 146,800 | D |
| Stock Option (right to buy)F3,F2 | $5.86 | holding | — | — | — | May 28, 2010 | May 28, 2019 | Common Stock | 0 | 56,700 | D |
| Stock Option (right to buy)F3,F2 | $10.03 | holding | — | — | — | Jun 3, 2011 | Jun 3, 2020 | Common Stock | 0 | 105,000 | D |
| Stock Option (Right to Buy)F3,F2 | $22.44 | holding | — | — | — | May 22, 2013 | May 22, 2022 | Common Stock | 0 | 50,000 | D |
| Stock Option (Right to Buy)F3,F2 | $23.15 | holding | — | — | — | May 14, 2014 | May 14, 2024 | Common stock | 0 | 21,250 | D |
| Stock Option (right to buy)F3 | $21.55 | holding | — | — | — | May 14, 2015 | May 14, 2024 | Common Stock | 0 | 85,000 | D |
Explanation of responses
- F1Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- F10This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.7000 and $68.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F11This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.7000 and $69.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F12This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.7000 and $69.9600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F2These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- F3Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F4These options become exercisable based on the achievement of certain performance milestones.
- F5Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $63.6200 and $64.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $64.6200 and $65.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $65.6750 and $66.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F9This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $66.7000 and $67.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.